Capping more than two years of stock-gyrating drama, Pfizer said Monday that it would stop development of danuglipron, its ...

The decision to stop developing danuglipron adds to a string of setbacks in the pharmaceutical giant's bid to win a slice of ...

India’s weight loss category is undergoing a dynamic transformation triggered by scientific improvements, pharma innovation, ...

The drugmaker said one patient became ill after being treated with its experimental weight-loss drug, danuglipron.